Enliven Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 14K | 46K | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -14K | -46K | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 20.7M | 21.2M | 18.2M | 21.5M | 24.9M | 20.7M | 21.3M | 18.8M |
| Operating Expenses | 27.8M | 34.2M | 25.1M | 28.6M | 31.7M | 26.9M | 27.1M | 24.6M |
| Operating Income | -27.8M | -34.3M | -25.1M | -28.6M | -31.7M | -26.9M | -27.1M | -24.6M |
| Other Income / Gains | 4.2M | 4.6M | 4.9M | 3.2M | 3.1M | 3.7M | 3.9M | 4.9M |
| Net Income | -23.6M | -29.7M | -20.1M | -25.3M | -28.5M | -23.2M | -23.2M | -19.9M |
| EPS (Diluted) | -0.38 | -0.45 | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 | -0.41 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 7.1M | 13.0M | 6.9M | 7.1M | 6.8M | 6.2M | 5.8M | 5.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 7.1M | 13.0M | 6.9M | 7.1M | 6.8M | 6.2M | 5.8M | 5.8M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 27.8M | 34.3M | 25.1M | 28.6M | 31.7M | 26.9M | 27.1M | 24.6M |
| Interest Income | 4.2M | 4.6M | 4.9M | 3.3M | 3.2M | 3.7M | 3.8M | 4.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 14K | 46K | 62K | 81K | 74K | 80K | 80K | 78K |
| Ebitda | -27.8M | -34.2M | -20.1M | -28.5M | -31.6M | -26.8M | -27.0M | -24.5M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -23.6M | -29.7M | -20.1M | -25.3M | -28.5M | -23.2M | -23.2M | -19.7M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 232K |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.38 | -0.45 | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 | -0.41 |
| Weighted Average Shs Out | 62.8M | 56.7M | 62.1M | 52.1M | 50.1M | 49.9M | 48.3M | 48.1M |
| Weighted Average Shs Out Dil | 62.8M | 56.7M | 62.1M | 52.1M | 50.1M | 49.9M | 48.3M | 48.1M |